Allianz Asset Management GmbH Has $53.21 Million Holdings in Agilent Technologies, Inc. $A

Key Points

• Allianz Asset Management increased its Agilent Technologies stake by 11.8% in the second quarter, adding 42,380 shares to own 400,557 shares valued at approximately $53.21 million.
• Analysts maintain a favorable outlook, with 1 Strong Buy, 15 Buy, and 4 Hold ratings, producing a consensus “Moderate Buy” rating and an average price target of $170.33.
• Agilent exceeded quarterly expectations with $1.62 in earnings per share versus $1.49 expected and $1.88 billion in revenue, up 8.1% year over year; the company guided to fiscal 2026 EPS of $6.18–$6.21.

Allianz Asset Management GmbH lifted its holdings in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 11.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 400,557 shares of the medical research company's stock after purchasing an additional 42,380 shares during the quarter. Allianz Asset Management GmbH owned 0.14% of Agilent Technologies worth $53,206,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. SHP Wealth Management acquired a new position in Agilent Technologies during the 4th quarter worth approximately $26,000. Core Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $26,000. Navalign LLC bought a new stake in shares of Agilent Technologies in the fourth quarter worth $27,000. Markowski Investments bought a new stake in shares of Agilent Technologies in the second quarter worth $27,000. Finally, MV Capital Management Inc. acquired a new position in Agilent Technologies during the fourth quarter worth $28,000.

Wall Street Analyst Weigh In

A has been the subject of a number of analyst reports. Robert W. Baird raised their target price on shares of Agilent Technologies from $155.00 to $156.00 and gave the company an "outperform" rating in a research report on Tuesday, May 26th. Wolfe Research restated a "hold" rating on shares of Agilent Technologies in a research note on Tuesday, June 2nd. Royal Bank Of Canada raised their price objective on Agilent Technologies from $155.00 to $185.00 and gave the company an "outperform" rating in a report on Thursday, August 27th. Barclays lifted their target price on Agilent Technologies from $150.00 to $175.00 and gave the company an "overweight" rating in a research report on Thursday, August 27th. Finally, Citigroup increased their price target on Agilent Technologies from $185.00 to $190.00 and gave the company a "buy" rating in a research report on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $170.33.

Agilent Technologies Stock Performance

A opened at $150.60 on Tuesday. The company has a quick ratio of 1.56, a current ratio of 2.05 and a debt-to-equity ratio of 0.50. Agilent Technologies, Inc. has a 12-month low of $108.35 and a 12-month high of $163.75. The business has a 50 day moving average of $142.62 and a 200-day moving average of $128.08. The stock has a market cap of $42.46 billion, a price-to-earnings ratio of 29.65, a PEG ratio of 2.30 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.49 by $0.13. The company had revenue of $1.88 billion for the quarter, compared to analyst estimates of $1.84 billion. Agilent Technologies had a net margin of 19.53% and a return on equity of 24.45%. The company's revenue was up 8.1% on a year-over-year basis. During the same period in the prior year, the firm earned $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities research analysts expect that Agilent Technologies, Inc. will post 6.2 earnings per share for the current year.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.